相关实验视频
Updated: Jun 7, 2025
07:07
A Melanoma Patient-Derived Xenograft Model
Published on: May 20, 2019
12.3K
一个缺失的效果机制:习惯地重述故事的人如何对黑色素瘤叙述有不同的 (或不那么不同的) 反应
Helen M Lillie1, Manusheela Pokharel2, Jakob D Jensen3
1Department of Communication Studies, University of Iowa, Iowa City, Iowa, USA.
Journal of health communication
|November 17, 2024
概括
那些习惯性地重新编剧故事的人在阅读悲剧结局后,显示出更多的黑色素瘤预防意图. 这种效应是特定于习惯性的重编剧和悲剧叙事,其他因素无法解释这种说服力.
科学领域:
- 心理学 心理学 心理学
- 卫生沟通健康沟通
- 叙事说服力是一种说服力.
背景情况:
- 读者经常在脑海中修改故事的不良结局,这个过程被称为重新编剧.
- 重构的认知和情感元素可以影响叙事说服力.
- 习惯性重绘对说服力的影响,特别是与健康相关的叙述,需要进一步调查.
研究的目的:
- 调查是否习惯性重编剧与非习惯性重编剧相比,对悲剧故事结局的说服力更强.
- 检查认知和情感重构在这种说服力效应中的调解作用.
- 用黑色素瘤叙述来测试这些假设.
主要方法:
- 一个随机的在线实验,有432名参与者接触到黑色素瘤叙述.
- 参与者被分配到一个主角的死亡或生存结束在六个特定的故事变化.
- 测量了黑色素瘤预防意图和重新绘制行为/情绪.
主要成果:
- 习惯性地重新编剧的参与者在阅读死亡结局与生存结局后,显示出明显更高的黑色素瘤预防意图.
- 这种相互作用效应并没有在不习惯地重复插图的参与者中观察到.
- 与假设相反,重新策划的认知和情感方面并没有调解观察到的说服力效应.
结论:
- 习惯性重新编剧更容易被悲惨的叙事结局所说服,特别是关于黑色素瘤预防意图.
- 驱动习惯性重绘者的这种增强说服力的机制仍然不清楚,需要进一步研究.
- 未来的研究应该探讨为什么习惯性重构者更容易受到来自负面叙事结果的说服的替代解释.
相关概念视频
01:30Skin Cancer
3.8K
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
3.8K
02:21Cancers Originate from Somatic Mutations in a Single Cell
11.7K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
11.7K
02:49Cancer Therapies
7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K
02:56Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
01:05Cancer-Critical Genes II: Tumor Suppressor Genes
7.3K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.3K
02:07Tumor Progression
6.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.2K